- Home
- APLM vs VEEE Comparison
APLM vs VEEE Comparison
Compare APLM & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- VEEE
- Stock Information
- Founded
- APLM 2016
- VEEE 1994
- Country
- APLM United States
- VEEE United States
- Employees
- APLM N/A
- VEEE N/A
- Industry
- APLM Blank Checks
- VEEE Marine Transportation
- Sector
- APLM Finance
- VEEE Industrials
- Exchange
- APLM Nasdaq
- VEEE Nasdaq
- Market Cap
- APLM 6.1M
- VEEE 5.8M
- IPO Year
- APLM N/A
- VEEE 2021
- Fundamental
- Price
- APLM $5.48
- VEEE $1.94
- Analyst Decision
- APLM
- VEEE
- Analyst Count
- APLM 0
- VEEE 0
- Target Price
- APLM N/A
- VEEE N/A
- AVG Volume (30 Days)
- APLM 33.5K
- VEEE 298.2K
- Earning Date
- APLM 09-16-2025
- VEEE 08-07-2025
- Dividend Yield
- APLM N/A
- VEEE N/A
- EPS Growth
- APLM N/A
- VEEE N/A
- EPS
- APLM N/A
- VEEE N/A
- Revenue
- APLM $198,000.00
- VEEE $13,153,262.00
- Revenue This Year
- APLM $415.15
- VEEE N/A
- Revenue Next Year
- APLM N/A
- VEEE N/A
- P/E Ratio
- APLM N/A
- VEEE N/A
- Revenue Growth
- APLM N/A
- VEEE N/A
- 52 Week Low
- APLM $3.66
- VEEE $1.86
- 52 Week High
- APLM $35.98
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- APLM 49.97
- VEEE 42.41
- Support Level
- APLM $3.66
- VEEE $1.94
- Resistance Level
- APLM $6.37
- VEEE $3.04
- Average True Range (ATR)
- APLM 0.54
- VEEE 0.19
- MACD
- APLM -0.10
- VEEE 0.01
- Stochastic Oscillator
- APLM 67.17
- VEEE 6.78
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.